Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.
Nitric oxide (NO) has antimicrobial activity against a wide spectrum of infectious pathogens, but an antiviral effect has not been reported.
The impact of NO, from endogenous and exogenous sources, on herpes simplex virus type 1 (HSV 1) replication was studied in vitro.
HSV 1 replication in RAW 264.7 macrophages was reduced 1,806-fold in monolayers induced to make NO by activation with gamma IFN and LPS. A competitive and a noncompetitive inhibitor of nitric oxide synthetase substantially reduced the antiviral effect of activated RAW macrophages.
S-nitroso-L-acetyl penicillamine (SNAP) is a donor of NO and was added to the media of infected monolayers to assess the antiviral properties of NO in the absence of gamma IFN and LPS. A single dose of S-nitroso-L-acetyl penicillamine 3 h after infection inhibited HSV 1 replication in Vero, HEp2, and RAW 264.7 cells in a dose-dependent manner.
Neither virucidal nor cytocidal effects of NO were observed under conditions that inhibited HSV 1 replication. Nitric oxide had inhibitory effects, comparable to that of gamma IFN/LPS, on protein and DNA synthesis as well as on cell replication. This report demonstrates that, among its diverse properties, NO has an antiviral effect.
J Clin Invest. 1993 Jun; 91(6): 2446¨C2452.
Department of Internal Medicine, University of Cincinnati College of Medicine, OH 45267-0560.
K D Croen
Author information Copyright and License information Disclaimer
This article has been cited by other articles in PMC.
Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC443304/